Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis
Titel:
Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis
Auteur:
Gossage, David L. Cieslarová, Blanka Ap, Sophe Zheng, Hao Xin, Yan Lal, Preeti Chen, Guang Smith, Victoria Sundy, John S.